These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 28258898)

  • 1. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
    Cardenas CE; Mohamed ASR; Tao R; Wong AJR; Awan MJ; Kuruvila S; Aristophanous M; Gunn GB; Phan J; Beadle BM; Frank SJ; Garden AS; Morrison WH; Fuller CD; Rosenthal DI
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):532-540. PubMed ID: 28258898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.
    Amarasena I; Herschtal A; D'Costa I; Fua T; Tiong A; Geddes V; Tran P; Liu C; Corry J
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):541-546. PubMed ID: 28581395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer.
    Gogineni E; Schaefer D; Ewing A; Andraos T; DiCostanzo D; Weldon M; Christ D; Baliga S; Jhawar S; Mitchell D; Grecula J; Konieczkowski DJ; Palmer J; Jahraus T; Dibs K; Chakravarti A; Martin D; Gamez ME; Blakaj D
    Pract Radiat Oncol; 2024; 14(3):e205-e213. PubMed ID: 38237893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of quality assurance rounds in a Canadian radiation therapy department.
    Lefresne S; Olivotto IA; Joe H; Blood PA; Olson RA
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e117-21. PubMed ID: 23195781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of patient examination to clinical quality assurance in head and neck radiation oncology.
    Rosenthal DI; Asper JA; Barker JL; Garden AS; Chao KS; Morrison WH; Weber RS; Ang KK
    Head Neck; 2006 Nov; 28(11):967-73. PubMed ID: 16823872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
    Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection.
    Mackenzie J; Graham G; Olivotto IA
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e192-e198. PubMed ID: 27633327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in treatment planning calculations motivated by tightening IMRT QA tolerances.
    Stambaugh C; Gagneur J; Uejo A; Clouser E; Ezzell G
    J Appl Clin Med Phys; 2019 Jan; 20(1):250-257. PubMed ID: 30599085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a real time group consensus peer review process in radiation oncology: an evaluation of effectiveness and feasibility.
    Albert AA; Duggar WN; Bhandari RP; Vengaloor Thomas T; Packianathan S; Allbright RM; Kanakamedala MR; Mehta D; Yang CC; Vijayakumar S
    Radiat Oncol; 2018 Dec; 13(1):239. PubMed ID: 30509283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer.
    Thomson DJ; Beasley WJ; Garcez K; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Med Dosim; 2016; 41(2):154-8. PubMed ID: 26993081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Target volume delineation for head and neck cancer intensity-modulated radiotherapy].
    Lapeyre M; Toledano I; Bourry N; Bailly C; Cachin F
    Cancer Radiother; 2011 Oct; 15(6-7):466-72. PubMed ID: 21880533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
    Hansen CR; Johansen J; Samsøe E; Andersen E; Petersen JBB; Jensen K; Andersen LJ; Sand HMB; Bertelsen AS; Grau C
    Radiother Oncol; 2018 Jan; 126(1):43-47. PubMed ID: 28987748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.
    Chao KS; Ozyigit G; Tran BN; Cengiz M; Dempsey JF; Low DA
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):312-21. PubMed ID: 12527043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Cardenas CE; Blinde SE; Mohamed ASR; Ng SP; Raaijmakers C; Philippens M; Kotte A; Al-Mamgani AA; Karam I; Thomson DJ; Robbins J; Newbold K; Fuller CD; Terhaard C
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):426-436. PubMed ID: 35124134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer.
    Chen AM; Chin R; Beron P; Yoshizaki T; Mikaeilian AG; Cao M
    Radiother Oncol; 2017 Jun; 123(3):412-418. PubMed ID: 28511960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.
    Braunstein S; Glastonbury CM; Chen J; Quivey JM; Yom SS
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):146-153. PubMed ID: 27811130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.
    Kry SF; Molineu A; Kerns JR; Faught AM; Huang JY; Pulliam KB; Tonigan J; Alvarez P; Stingo F; Followill DS
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1195-201. PubMed ID: 25442044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
    Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
    Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.